CTT Pharmaceutical Holdings Inc
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.… Read more
CTT Pharmaceutical Holdings Inc (CTTH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.200x
Based on the latest financial reports, CTT Pharmaceutical Holdings Inc (CTTH) has a cash flow conversion efficiency ratio of -0.200x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-16.39K) by net assets ($82.14K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CTT Pharmaceutical Holdings Inc - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how CTT Pharmaceutical Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CTT Pharmaceutical Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CTT Pharmaceutical Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Indigo Exploration Inc.
PINK:IXIXF
|
-0.723x |
|
Solvbl Solutions Inc
PINK:SOLBF
|
-0.017x |
|
Alma Gold Inc
PINK:ALGLF
|
N/A |
|
Haloni Jane
JK:HALO
|
-0.026x |
|
INSMED
BE:IM8N
|
-0.374x |
|
ATI Physical Therapy Inc
NYSE:ATIP
|
-0.071x |
|
EQUIFAX INC - Dusseldorf Stock Exchang
DU:EFX
|
0.095x |
|
MetaVia Inc.
NASDAQ:MTVA
|
-0.467x |
Annual Cash Flow Conversion Efficiency for CTT Pharmaceutical Holdings Inc (1999–2024)
The table below shows the annual cash flow conversion efficiency of CTT Pharmaceutical Holdings Inc from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $32.18K | $-228.32K | -7.094x | -1918.93% |
| 2023-12-31 | $60.03K | $-21.10K | -0.351x | +77.41% |
| 2022-12-31 | $89.25K | $-138.84K | -1.556x | +98.63% |
| 2021-12-31 | $5.28K | $-600.25K | -113.770x | -17620.11% |
| 2020-12-31 | $-286.77K | $-186.22K | 0.649x | +120.42% |
| 2019-12-31 | $122.77K | $-390.45K | -3.180x | -430.76% |
| 2018-12-31 | $500.10K | $-299.66K | -0.599x | -136.98% |
| 2017-12-31 | $-89.58K | $-145.16K | 1.620x | +2731.26% |
| 2016-12-31 | $-105.86K | $-6.06K | 0.057x | +241.71% |
| 2015-12-31 | $335.13K | $-13.54K | -0.040x | +67.21% |
| 2014-12-31 | $586.63K | $-72.25K | -0.123x | -184.10% |
| 2014-02-28 | $-31.18K | $-4.57K | 0.146x | -73.86% |
| 2013-12-31 | $-243.13K | $-136.23K | 0.560x | -78.92% |
| 2012-12-31 | $-386.33K | $-1.03 Million | 2.658x | +483.83% |
| 2011-12-31 | $456.45K | $-316.13K | -0.693x | +99.95% |
| 2010-12-31 | $1.35K | $-1.78 Million | -1322.300x | -321776.83% |
| 2009-12-31 | $-1.25 Million | $-513.28K | 0.411x | +110.27% |
| 2008-12-31 | $151.39K | $-605.93K | -4.003x | -55.28% |
| 2007-12-31 | $557.86K | $-1.44 Million | -2.578x | -196.28% |
| 2006-12-31 | $765.03K | $-665.55K | -0.870x | +95.77% |
| 2005-12-31 | $74.21K | $-1.53 Million | -20.565x | -2368.14% |
| 2004-12-31 | $1.92 Million | $-1.60 Million | -0.833x | -221.66% |
| 2003-12-31 | $-1.71 Million | $-1.17 Million | 0.685x | -27.94% |
| 2002-12-31 | $-577.76K | $-549.08K | 0.950x | +20559.22% |
| 2001-12-31 | $-17.61K | $-81.00 | 0.005x | -99.62% |
| 2000-12-31 | $-87.85K | $-104.99K | 1.195x | -31.95% |
| 1999-12-31 | $-83.44K | $-146.55K | 1.756x | -- |